ArticlePloS one2025
Assessing uncertainty: A study of entropy measures for Burr XII distribution under progressive Type-II censoring.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research study focuses on calculating five entropy measures (Shannon, Rényi, Havrda-Charvát, Arimoto, and Tsallis) for the Burr XII distribution, utilizing progressive Type-II censoring. The study derives maximum likelihood estimators for each entropy measure and constructs two-sided confidence intervals. A comprehensive simulation study evaluates the performance of these estimators across various sample sizes and parameter settings. The results demonstrate that the proposed methods achieve low bias and variance under different censoring schemes, with coverage probabilities consistently close to the nominal level. Additionally, an application to the Wisconsin Breast Cancer Database highlights the practical utility of the entropy estimators in distinguishing between benign and malignant cases. Among the measures evaluated, the Rényi, Havrda-Charvát entropy measures exhibited the most robust performance in both simulation and real life data analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.